A Trial Evaluating Omission of Radiotherapy to Regional Lymphatic's

The present study is a phase II/III prospective randomized trial designed to determine whether eliminating of post operative radiotherapy to regional lymphatics in pN0-N1oral cavity is associated with similar treatment outcomes.

Trial Details

NCT ID
NCT07528495
Phase
PHASE2 / PHASE3
Sponsor
All India Institute of Medical Sciences
Status
RECRUITING
Cancer Type
Head and Neck Cancer
Interventions
  • IMRT - adjuvant concurrent CRT/ RT
  • ommission of IMRT - adjuvant concurrent CRT/ RT for regional lymphatics
  • Cisplatin
Locations (sample)
  • Jhajjar, Haryana, India|28.6063,76.6565

Key Eligibility Criteria

  • Aged 18 or above and less than 70 years
  • Stage pT1-4histological confirmed squamous cell carcinoma of oral cavity undergoing radical excision and ipsilateral/bilateral neck dissection.
  • Patient with high risk features: positive or close (≤ 5mm) margin, presence of LVI or PNI, pT3-4
  • At least one dissected hemi-neck (at least 12 nodes recovered in one dissected hemi-neck)

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Head and Neck Cancer Trials on Trialify →